Product Information
RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.7967 per EA under NDC 33342048809. Its NADAC has been published 51 times since Jul 9, 2025.
Strength
2.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342048809
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA213114On Market Since
5/14/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 51 times since Jul 9, 2025, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7967 per EA |
|---|---|
| All-time high | $4.6446 (Aug 13, 2025) |
| All-time low | $0.7967 (Jun 17, 2026) |
| 52-week high | $4.6446 |
| 52-week low | $0.7967 |
| Median price | $1.4044 |
| Average price | $2.1142 |
| Largest weekly change | -32.4% (Nov 19, 2025) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.7967 per EA (NDC 33342048809), effective Jun 24, 2026.
How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 82.5%. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?
Since Jul 9, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.7967 (Jun 17, 2026) to a high of $4.6446 (Aug 13, 2025), with a median of $1.4044 per EA.
Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as RIVAROXABAN 2.5 MG TABLET, but none are currently priced below it.
Who manufactures RIVAROXABAN 2.5 MG TABLET?
RIVAROXABAN 2.5 MG TABLET (NDC 33342048809) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification